Europe Approves Bristol-Myers Squibb Opdivo for Advanced RCC

The European Commission has approved Opdivo (nivolumab) monotherapy for an additional indication in advanced renal cell carcinoma (RCC) after prior therapy in adults, announced Bristol-Myers Squibb Company. To demonstrate an overall survival (OS) benefit versus a standard of care in this patient population, Opdivo is the first and only PD-1 immune checkpoint inhibitor approved in Europe. The approval…

DARPA’s anti-submarine drone

ACTUV can detect, monitor, do reconnaissance and even deliver supplies to friendlies in hostile waters. DARPA’s 130 feet drone is a ship that can effectively eliminate enemy submarines. Although its christening is slated to take place On April 7, its currently harbored in waters nears its construction site in Portland, Oregon. DARPA has even begun…